|
US20020072509A1
(en)
*
|
2000-10-11 |
2002-06-13 |
Stein Donald Gerald |
Methods for the treatment of a traumatic central nervous system injury
|
|
SE0104423D0
(sv)
|
2001-12-27 |
2001-12-27 |
Umecrine Ab |
Pregnane steroids and their use in the treatment of CNS disorders
|
|
RU2413516C2
(ru)
*
|
2004-11-18 |
2011-03-10 |
Умекрин Аб |
Гамк-стероидные антагонисты и их применение в лечении нарушений цнс
|
|
WO2006054938A1
(en)
*
|
2004-11-18 |
2006-05-26 |
Umecrine Ab |
Gaba-steroid antagonists and their use for the treatment of cns disorders
|
|
DE102006003508A1
(de)
*
|
2006-01-24 |
2007-07-26 |
Grünenthal GmbH |
Arzneimittel umfassend eine Hormonkombination
|
|
DE102006003509A1
(de)
*
|
2006-01-24 |
2007-07-26 |
Grünenthal GmbH |
Kontrazeptivum
|
|
US20070203216A1
(en)
*
|
2006-02-14 |
2007-08-30 |
Bjarke Ebert |
Method of treating inflammatory diseases
|
|
DK2097437T3
(en)
|
2006-11-21 |
2015-06-29 |
Umecrine Cognition Ab |
THE USE OF PREGNANCY AND ANDROSTANOSTEROIDS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF CNS DISEASES
|
|
WO2008154579A1
(en)
*
|
2007-06-11 |
2008-12-18 |
University Of Southern California |
Allopregnanolone in a method for enhancing neurological function (alzheimer disease)
|
|
US20100204192A1
(en)
|
2007-06-11 |
2010-08-12 |
University Of Sourthern California |
Agents, compositions and methods for enhancing neurological function
|
|
US20090048288A1
(en)
*
|
2007-08-13 |
2009-02-19 |
H. Lundbeck A/S |
Method of treating stress-mediated depression
|
|
HUE027298T2
(en)
*
|
2010-01-14 |
2016-10-28 |
Asarina Pharma Ab |
Pharmaceutical composition containing developed storage and dissolution properties containing 3-beta-hydroxy-5-alpha-pregnan-20-one
|
|
AU2012260955B2
(en)
*
|
2011-05-20 |
2017-08-17 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Antagonists of CB1 receptor.
|
|
US10478505B2
(en)
|
2011-09-23 |
2019-11-19 |
The Regents Of The University Of California |
Edible oils to enhance delivery of orally administered steroids
|
|
SG10201606063RA
(en)
*
|
2012-01-23 |
2016-09-29 |
Sage Therapeutics Inc |
Neuroactive steroid formulations and methods of treating cns disorders
|
|
US20140050789A1
(en)
|
2012-08-13 |
2014-02-20 |
The Regents Of The University Of California |
Mitigation of epileptic seizures by combination therapy using benzodiazepines and neurosteroids
|
|
MX2015002252A
(es)
|
2012-08-21 |
2015-07-21 |
Sage Therapeutics Inc |
Metodos para tratar epilepsia o estado de epilepsia.
|
|
AU2013351190B2
(en)
|
2012-11-28 |
2018-03-29 |
Alienor Farma |
3-(4'-substituted)-benzyl-ether derivatives of pregnenolone
|
|
DK2925327T3
(da)
*
|
2012-11-30 |
2024-03-25 |
Univ California |
Allopregnanolon til behandling, reduktion eller lindring af symptomer på fødselsdepression
|
|
AU2015212606B2
(en)
|
2014-01-29 |
2019-11-21 |
Umecrine Cognition Ab |
Steroid compound for use in the treatment of hepatic encephalopathy
|
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
|
WO2016082789A1
(en)
*
|
2014-11-27 |
2016-06-02 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
|
AR103384A1
(es)
|
2015-01-12 |
2017-05-03 |
Umecrine Cognition Ab |
3a-ETINILO, 3b-HIDROXI, 5a-PREGNAN-20-OXIMA COMO MODULADOR DE GABA
|
|
HK1258616A1
(zh)
|
2016-03-08 |
2019-11-15 |
Sage Therapeutics, Inc. |
神经活性类固醇、组合物、及其用途
|
|
US10278977B2
(en)
|
2016-06-06 |
2019-05-07 |
Umecrine Cognition Ab |
Methods for treating hypersomnolence
|
|
DK3565528T3
(da)
*
|
2017-01-09 |
2025-05-26 |
Relmada Therapeutics Inc |
Injicerbare suspensioner
|
|
EP3579842A4
(en)
|
2017-02-10 |
2020-12-23 |
Asarina Pharma AB |
3-BETA-HYDROXY-5-ALPHA-PRÉGNAN-20-ONE FOR USE IN THE TREATMENT OF ESSENTIAL TREMMENTS
|
|
JP7179739B2
(ja)
*
|
2017-02-10 |
2022-11-29 |
アサリナ ファーマ アーベー |
医学的治療における使用のための３－β－ヒドロキシ－５－α－プレグナン－２０－オン
|
|
WO2019075362A1
(en)
*
|
2017-10-12 |
2019-04-18 |
Sage Therapeutics, Inc. |
METHOD OF TREATING CENTRAL NERVOUS SYSTEM DISORDERS WITH NEUROSTEROIDS AND GABAERGIC COMPOUNDS
|
|
MX2020010219A
(es)
|
2018-04-05 |
2020-11-09 |
Asarina Pharma Aps |
Antagonistas de gaba-a para tratar trastornos por abstinencia de sustancia.
|
|
KR20240050372A
(ko)
|
2021-09-14 |
2024-04-18 |
난징 미노바 파마슈티컬 컴퍼니, 리미티드 |
수용성 알로프레그나놀론 유도체 및 이의 제조 방법과 용도
|
|
EP4429669A1
(en)
|
2021-11-10 |
2024-09-18 |
Umecrine AB |
Steroid as a modulator of gabaa receptor
|
|
US20250387409A1
(en)
|
2021-11-10 |
2025-12-25 |
Umecrine Cognition Ab |
3-beta-hydroxy-3-alpha-ethyl steroids for modulation of the alpha-3 subtype of the gabaa receptor
|
|
WO2023083978A1
(en)
|
2021-11-10 |
2023-05-19 |
Umecrine Ab |
3.alpha.-substituted 3.beta.-hydroxy 17-oximated androstane compound for modulation of the alpha-3 subtype of the gaba-a receptor
|